President Joe Biden's proposal to have GLP-1 weight-loss drugs such as Wegovy, Ozempic, Zepbound and Mounjaro covered by Medicare and Medicaid would help tackle the public-health crisis of obesity, ...
Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.
Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...
Understanding Medicare basics may be one of the most maddening tasks you'll face when heading into retirement. Figuring out when to enroll in Medicare and which parts of Medicare to elect can be ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
Access to the medication is limited, especially since medications like Wegovy and Zepbound are not covered by most government ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback